Urinary Tract Infections
Conditions
Keywords
herbal treatment, antibiotics, uncomplicated urinary tract infection
Brief summary
Observational follow-up study of patients included in the clinical trial REGATTA.
Detailed description
A follow-up telephone interview of the participants of the clinical trial REGATTA exploring the occurrence of urinary tract infections, pyelonephritis within a follow-up period of three months after inclusion.
Interventions
DRUGArctuvan
application of a herbal drug in the clinical trial REGATTA (NCT03151603)
application of Placebo to Fosfomycin in the clinical trial REGATTA (NCT03151603)
DRUGFosfomycin
application of an antibiotic drug in the clinical trial REGATTA (NCT03151603)
application of Placebo to Arctuvan in the clinical trial REGATTA (NCT03151603)
Sponsors
University Medical Center Goettingen
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* participants of the clinical trial REGATTA * informed consent to participate in the observational study REGATTA II
Exclusion criteria
\- no informed consent granted
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| number of urinary tract infections | 3 months after inclusion in REGATTA | number of urinary tract infection within 3 months after inclusion in REGATTA |
| number of pyelonephritis | 3 months after inclusion in REGATTA | number of pyelonephritis within 3 months after inclusion in REGATTA |
Countries
Germany
Outcome results
None listed